CinCor Pharma, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
CinCor Pharma, Inc. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q2 2021 to Q3 2022.
  • CinCor Pharma, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2022 was -$21.1M, a 134% decline year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$21.1M -$12.1M -134% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$21.5M -$15.1M -236% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q3 2021 -$9.02M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$6.38M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.